COPD progression and individual rates of change in FEV 1and the BODE index

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 9, 2011, Pages 988-990

  Tashkin, Donald P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY OBSTRUCTION; BODY MASS; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE COURSE; DISEASE EXACERBATION; DYSPNEA; EDITORIAL; EXERCISE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MEASUREMENT; MORTALITY; PREDICTION; PRIORITY JOURNAL; SPIROMETRY;

FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 80955182287     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201108-1507ED     Document Type: Editorial

References (10)

1. Han MLK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbr LM, Goldin JG, Jones PW, MacNee W, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010;182:598-604.
2. Rennard SI, Vestbo J. The many "small COPDs": COPD should be an orphan disease. Chest 2008;134:623-627.
3. Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, Pare PD. Susceptibility genes for rapid decline of lung function in the Lung Health Study. Am J Respir Crit Care Med 2001;163:469-473. (Pubitemid 32158530)
4. He JQ, Foreman MG, Shumanssky K, Zhang X, Akhabir L, Sin DD, Man SF, DeMeo DL, Litonjua AA, Silverman EK, et al. Associatons of IL6 polymorphisms with lung function decline and COPD. Thorax 2009;64:690-704.
5. Hurst J, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Aguisti A, MacNee W, et al. Frequency, determinants and impact of exacerbations in a large cohort with chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-1138.
6. Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-852.
7. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Exercise deterioration in patients with COPD: longitudinal evaluation over 5 years. Chest 2005;128:62-69.
8. Celli BR, Cote C, Marin JE, Casanova C, Montes de Oca M, Mendez R Plata VP, Cabral HJ. The body mass index, airflow obstruction, dyspnea, exercise performance (BODE) index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012.
9. Casanova C, de Torres J, Aguirre-Jaime A, et al. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am J Respir Crit Care Med 2011;184:1015-1021.
10. Enright PL, Connett JE, Kanner RE, Johnson LR, Lee WW, for the Lung Health Study Group. Spirometry in the Lung Health Study: II. Determinants of short-term intraindividual variability. Am J Respir Crit Care Med 1995;151:406-411.